Log In
Print
BCIQ
Print
Print this Print this
 

LE-MPP, Loteprednol etabonate mucosal penetrating particle (KPI-121)

  Manage Alerts
Collapse Summary General Information
Company Kala Pharmaceuticals Inc.
DescriptionLoteprednol etabonate, a steroid, delivered using mucus-penetrating nanoparticles
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today